ClinConnect ClinConnect Logo
Search / Trial NCT04672174

Cognitive Screening of Patients with Hearing Loss

Launched by UNIVERSITY OF ZURICH · Dec 10, 2020

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Cognitive impairment and dementia are a growing health-care problem in our society. The prevalence of dementia is still estimated to grow drastically and reach over a 100 million world-wide by the year 2050. To address this problem there are numerous neuropsychological screening methods, for example the mini-mental state examination (MMSE) or the DemTect.

Another age-dependent problem is the increasing hearing impairment. Furthermore, studies have shown that hearing loss is associated with cognitive decline and may accelerate the process. Nevertheless, there is no specific cognitive screen...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Age 50 - 90
  • Measurable hearing loss
  • Sufficient knowledge of german
  • Ability to consent
  • Exclusion Criteria:
  • Age \< 50 or \>90
  • No measurable hearing loss
  • Present or past alcohol or drug abuse
  • Clinically relevant depressive symptoms
  • lnability to consent

About University Of Zurich

The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.

Locations

Zurich, , Switzerland

Patients applied

0 patients applied

Trial Officials

Christof Roosli

Principal Investigator

UniversitätsSpital Zürich, ORL-Klinik

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials